Send by santé log

Ce résultat préliminaire de suivi à 5 ans a été présenté jeudi lors du 26e congrès international ECTRIMS, l'un des principaux sur la SEP, à Göteborg (Suède) [...]

Send by MarketWatch (press release)

These accumulated efficacy and safety data were presented in Sweden at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) [...]

Overview: ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis) is the world's largest professional organization dedicated to the [...]

The 2010 RIMS Conference is approaching and as you already know, it is organised as a joint ECTRIMS-RIMS in Gothenburg, Sweden, 13-16 October, 2010. [...]

ECTRIMS hosts the world's largest annual international conference devoted to basic and clinical research in multiple sclerosis. Price: Enter price here [...]

Hans-Peter Hartung President, ECTRIMS. Carlos Oehninger President, LACTRIMS ECTRIMS congress. Düsseldof, Germany. August 2010. LACTRIMS congress [...]

-- TYSABRI redefines expectations of multiple sclerosis therapy for some patients -- Düsseldorf, Germany – Sept. 11, 2009 – Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced data presented at the 25th [...]

Send by Bill

Effective diagnosis and management of patients with multiple sclerosis (MS) were 2 topics discussed during the ECTRIMS 2007: 23rd Congress of the European Committee for Treatment and Research in Multiple Sclerosis; October 11-14, 2007; [...]

Send by Gordon

Detailed information on social events and other activities taking place in conjunction with the ECTRIMS congress are provided, together with resources to help you preparing your stay in Gothenburg, Sweden. [...]

Send by Bill

Advances in clinical trial design and in the treatment of multiple sclerosis (MS) were presented during the 22nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), September 27-30, 2006, [...]

Send by www.businesswire.com

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq:XNPT) announced today that it will present data on a new preclinical product candidate, XP23829, at the upcoming 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) meeting in Gothenburg, Sweden, October 13 - 16, 2010. Data from the poster presentation show that compared to [...]

Send by hollie

This one is on Medscape (free registration required). You'll find an interview with Dr. Mark Freedman, overviews of some of the topics presented (new treatment results, quality of life issues, use of MRI and other diagnostic tools, etc. [...]

Send by www.businesswire.com

JERUSALEM, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that more than 20 scientific abstracts supporting its multiple sclerosis (MS) franchise will be presented at the 26th Annual Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Gothenburg, Sweden, October 13-16, 2010. Key featured data include [...]

Summary: Recent reports are calling attention to the idea that a phenomenon called CCSVI, a reported abnormality in blood drainage from the brain and spinal cord, may contribute to nervous system damage in MS. This hypothesis has been put forth by Dr. Paulo Zamboni from the University of Ferrara in [...]

Darmstadt, Germany, September 11, 2009 – Merck KGaA announced today new data from a post-hoc analysis of the two-year (96-week) placebo-controlled CLARITY(1) [...]

Send by MDhealthChannel.com

These data are presented today at a satellite symposium at the 22nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Madrid, Spain. “These results are promising news for patients with [...]

This Friday, I will receive my 24th infusion of what many call the most effective treatment for Multiple Sclerosis currently on the market: Tysabri. Despite its effectiveness, the risk of PML (progressive multifocal leukoencephalopathy) continues to haunt neurologists who prescribe the treatment. Th [...]

Laquinimod presentations at ECTRIMS Market Wire - 1 hour ago. LUND, SWEDEN--(Marketwire - September 8, 2009) - Lund, Sweden, September 8, 2009 - Active Biotech ab's (NASDAQ OMX Nordic: ACTI) collaboration partner Teva Pharmaceutical [...]

Send by Francisco Acedo

Biogen Idec (NASDAQ: BIIB) anunció hoy que se presentarán más de 45 presentaciones y pósters patrocinados por la compañía durante el 26º Congreso del Comité Europeo para el Tratamiento e Investigación en Esclerosis Múltiple (ECTRIMS) [...]

Send by JensenH

XenoPort, Inc. (Nasdaq:XNPT) announced today that it will present data on a new preclinical product candidate, XP23829, at the upcoming 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) [...]

Send by Frontier India Pharmacetuicals

These accumulated efficacy and safety data were presented in Sweden at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) annual meeting, one of the largest annual international MS conferences. [...]

Biogen Idec today announced that more than 45 company and partner-sponsored platform and poster presentations will be presented during the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis ECTRIMS [...]

For a quarter of a century, ECTRIMS has served as Europe's and the world's largest professional organisation dedicated to the understanding and treatment of Multiple Sclerosis. [...]

Send by Alyoop

Yesterday at the ECTRIMS conference that I am attending in Goteburg, the Charcot foundation chose this as the topic for the symposium. Approx. 5000 neurologists attended. I am presenting to you a very brief synopsis of what was [...]

XenoPort to present XP23829 preclinical data at ECTRIMS meeting XenoPort, Inc. announced today that it will present data on a new preclinical product candidate, XP23829, at the upcoming 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) meeting in Goth [...]